Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LuminoMark injection for localization of nonpalpable breast lesions (Phase 2)
KCT0003798Phase 2Completed
- Sponsor
- Hanlim Pharm
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indocyanine green + hyaluronic acid in breast lesion, sponsored by Hanlim Pharm. Started May 2018; status: completed.
02
Drugs
indocyanine green + hyaluronic acid
03
Conditions
breast lesion
Beyond the preview
Go deeper on KCT0003798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003798.